SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer-Reference-Cited by-同舟云学术

SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer

Published:2015-07-15 Issue:2 Volume:112 Page:231-237
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Azuma Yoko¹,Yokobori Takehiko¹²,Mogi Akira¹,Altan Bolag¹,Yajima Toshiki¹,Kosaka Takayuki¹,Onozato Ryoichi¹,Yamaki Ei¹,Asao Takayuki³,Nishiyama Masahiko²,Kuwano Hiroyuki¹

Affiliation:

1. Department of General Surgical Science; Graduate School of Medicine; Gunma University; Maebashi Japan

2. Department of Pharmacology and Oncology; Graduate School of Medicine; Gunma University; Maebashi Japan

3. Department of Oncology Clinical Development; Gunma University; Maebashi Japan

Funder

Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science

Uehara Zaidan, Promotion Plan for the Platform of Human Resource Development for Cancer and New Paradigms-Establishing Centers for Fostering Medical Researchers of the Future programs

Ministry of Education, Culture, Sports, Science and Technology of Japan

Gunma University Initiative for Advanced Research

Yakult Honsha Co. Ltd.

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.23975/fullpdf

Reference20 articles.

1. Estimates of cancer incidence and mortality in Europe in 2008;Ferlay;Eur J Cancer,2010

2. Systemic therapy of advanced non-small cell lung cancer: Major-developments of the last 5-years;Cufer;Eur J Cancer,2013